Navigation Links
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Date:11/11/2009

NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that data from its Phase 1/2 clinical trial of KRX-0401 (perifosine) in combination with bortezomib (+/- dexamethasone) has been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009. The clinical data to be presented demonstrates the potential safety and efficacy of KRX-0401 in the treatment of patients with relapsed/refractory multiple myeloma.

    Details on the Abstract selected for poster presentation are as follows:

    Abstract #:         1869

    TITLE:  Perifosine in Combination with Bortezomib and Dexamethasone
    Extends Progression-Free Survival and Overall Survival in
    Relapsed/Refractory Multiple Myeloma Patients Previously Treated with
    Bortezomib: Updated Phase I/II Trial Results

    Lead Author:        Paul Richardson, MD

    Session Name:       Myeloma - Therapy, excluding Transplantation Poster I

    Date:               Saturday, December 5, 2009

    Presentation Time:  5:30 PM - 7:30 PM

    Location:           Ernest N. Morial Convention Center, Hall E

    Poster Board no.:   I-891

This abstract became available for viewing yesterday on the American Society of Hematology website (www.hematology.org). At the time of the abstract submission in mid-August 2009, there were 84 patients enrolled on study, of which 73 were evaluable for efficacy and are reported on within the abstract. Updated efficacy (response rate, time-to-progression and survival) and safety analyses, as of mid-November 2009, will be presented at the conference.

A copy of the above referenced abstract can be viewed online through the ASH website,

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
4. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
5. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
6. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
7. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
8. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
9. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
11. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 Reportbuyer.com has added a new ... Market 2014-2018 https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... is a special type of X-ray test used to ... used primarily to detect osteopenia or osteoporosis, diseases in ... of fractures is high. The purpose of bone densitometry ...
(Date:7/28/2014)... FRANCISCO, Calif. , July 28, 2014 ... provided an update on the status of the KB001-A ... with Sanofi Pasteur.  KB001-A Collaboration ... an agreement with Sanofi Pasteur to regain all rights ... and licensing agreement entered into in 2010 has been ...
(Date:7/28/2014)... WASHINGTON , July 28, 2014  Some 2,500 ... next month in Montreal for ... crystallography -- a discipline that draws researchers from fields ... solve problems as diverse as designing new manufacturing processes ... at a special time because the United Nations has ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5KaloBios Provides Update on KB001-A Partnership and Clinical Status 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 3KaloBios Provides Update on KB001-A Partnership and Clinical Status 4KaloBios Provides Update on KB001-A Partnership and Clinical Status 5KaloBios Provides Update on KB001-A Partnership and Clinical Status 6All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 2All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 3All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 4All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 6
... YORK, Sept. 28 Reportlinker.com announces that a ... catalogue: Global Magnetic Resonance ... http://www.reportlinker.com/p0304768/Global-Magnetic-Resonance-Imaging-MRI-Systems-Market-2010---2015.html ... Global Market (2008 – 2015) The ...
... N.J., Sept. 28 Prolong Pharmaceuticals today announced that industry ... Kazo has been consulting in various capacities with Prolong since ... Chief Executive Officer. "I have known Glenn for ... Pharmaceuticals in 1981 with Mr. Kazo. "I feel he is ...
Cached Medicine Technology:Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 2Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 3Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 4Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 5Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 6Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 7Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 8Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 9Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 10Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 11Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President 2
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading memory ... release of the fourth edition of The Brain Health ... , The Brain Health Guide is a unique resource ... to improve memory and promote optimal aging. Rather than ... Guide provides ways to help minimize common memory lapses ...
(Date:7/28/2014)... Philadelphia, PA (PRWEB) July 28, 2014 ... die each year from metastatic breast and prostate cancers ... when the cancer has spread to other parts of ... brain. Now researchers at Drexel University College of ... target they identified that inhibits metastatic progression by blocking ...
(Date:7/28/2014)... Dawn Echols’ professional background spans success in ... experience has honed her people skills and led ... counseling ( http://dawningphoenix.com ) work includes private practice, ... domestic violence. , As owner and executive ... individuals and groups for a variety of disorders. ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... just milliseconds to look at someone,s face and judge them ... that certain facial features seem to trigger specific first impressions ... of the mouth, for example, appear directly linked to whether ... The study findings suggest that first impressions are ...
(Date:7/28/2014)... July 28, 2014 (HealthDay News) -- Elementary school students seem ... to them, according to a new study of school officials. ... Department of Agriculture -- went into effect in the fall ... would stop buying lunch, or throw away most of their ... suggests that this isn,t the case. , , "The updated ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 2Health News:Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells 3Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Healthy School Lunches Get Thumbs Up From Students 2
... coronary artery , THURSDAY, Feb. 11 (HealthDay News) -- Former ... Thursday evening in a New York City hospital after he ... , The 63-year-old Clinton, who underwent quadruple bypass surgery in ... reports. , "Today President Bill Clinton was admitted to ...
... , CHICAGO , Feb. 11 ... of Frank Corbett , founder of Frank J. Corbett , ... "Frank was a pioneer in our industry, a legend, a leader for ... CEO, Scott D. Cotherman . "His passion and drive for our industry ...
... , CHICAGO , Feb. 11 The ... proud to announce the selection of attorney Jeffrey Schlapp to ... ® and Chicago Magazine 02/2010 . , When it ... nursing home industry itself on behalf of the injured becomes a game-changer. ...
... children with asthma often recognize signs that their child is ... until the attack occurs, researchers at Washington University School of ... published in the Annals of Allergy, Asthma and Immunology, ... thus relieve a child,s symptoms, possibly reduce the extent of ...
... ... charity Landlife and is giving away free wild flower seeds. Simply request free samples from ... 1st April through until May. , ... (PRWEB) February 13, 2010 -- The online window blinds retailer, Tuiss.co.uk , has ...
... aren,t conclusive, researchers say , THURSDAY, Feb. 11 (HealthDay ... that eating dark chocolate appears to lower your risk of ... , But the findings, based on a review of ... is good for your heart. And dietitians say too much ...
Cached Medicine News:Health News:Ex-President Clinton Undergoes Heart Procedure 2Health News:Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett 2Health News:Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett 3Health News:Beware the Gentle Man With Unique Knowledge: The Passion and Skill of a Rising Star 2Health News:Parents often wait too long to treat children's asthma symptoms 2Health News:Parents often wait too long to treat children's asthma symptoms 3Health News:Go Wild with Blinds Retailer Tuiss.co.uk and Environmental Charity Landlife 2Health News:Dark Chocolate May Lower Stroke Risk 2
... The design of the Hi-Top ... to be held back in ... shoe counter. The front is ... and compression on the toes. ...
... semi-rigid post op shoe is ideal for ... breathable upper will keep your patient both ... closure provides even tension and compression. The ... support for your patient. The black TPR ...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: